PT-141
A compounded bremelanotide injection that enters sexual response through central melanocortin signaling rather than genital blood flow.
A clinician-guided compounded oxytocin nasal spray for people exploring the social and emotional layer of intimacy.
From $99/month
Compounded by a licensed US pharmacy to an individual prescription. Compounded preparations are not FDA-approved drug products.
Sex can function perfectly and still feel different. Desire may be present. Physical response may be intact. What changed is harder to point to: closeness, presence, the emotional texture around the experience.
That is the layer that makes oxytocin interesting.
Oxytocin is a hormone and neuropeptide your body already makes. It is released during touch and orgasm and acts in brain systems involved in social and emotional processing. That puts it in a very different biological conversation from medications aimed at genital blood flow or physical arousal. Human researchers have studied intranasal oxytocin in sexual experience and partner interaction because those systems overlap.
The nickname “love hormone” makes the story sound cleaner than the evidence is. Oxytocin is not a switch for intimacy. It is a real biological signal inside a much more complicated human experience, which is exactly why it belongs in a clinician-guided conversation rather than a miracle claim.
Oxytocin is considered when your concern is closeness, presence, or the emotional texture of intimacy rather than mechanics. Its intended job is clear, and the limits of the evidence are equally clear.
The mechanics are still there. What changed is the sense of closeness around them. You want to look at intimacy as more than a performance problem without pretending one molecule can explain a relationship.
Stress, illness, grief, parenting, or work changed the rhythm between you. The body can still respond while the emotional experience of sex feels less available than it used to.
Desire, hormones, or physical function already have their own treatment plan. You are interested in the social and emotional biology that those interventions were never designed to address.
FDA-approved oxytocin products exist for specific obstetric uses. The preparation offered here is compounded for a different purpose and is not an FDA-approved drug product. A licensed provider determines candidacy from your full Assessment.
Your intake screens for all contraindications. Every candidate is evaluated by a licensed clinician before any prescription is issued. No prescription is issued without clearance.
Compounded by a licensed 503A pharmacy. Prescribed by a licensed provider after clinical review.
3-month commitment
Compounded by a licensed US pharmacy to an individual prescription. Compounded preparations are not FDA-approved drug products.
*Price reflects a 3 month commitment. Other billing options are shown at checkout.
Safety depends on the prescribed formulation, route, and dose. Your provider reviews pregnancy status, kidney function, fluid-balance history, medications, and other relevant conditions before prescribing. The compounded preparation offered here is used for a different purpose than FDA-approved obstetric oxytocin products.
If your provider determines you are not a candidate for any available treatment, any consultation fee paid will be refunded within 7–10 business days. You are not left guessing. Your clinician explains the reasoning and, where it helps, what a better path might look like. Reviews are typically completed in under 24 hours.
The biology is real, but the outcome is not settled. Some human studies have reported changes in specific aspects of sexual experience or partner interaction, while controlled studies have found no meaningful improvement in sexual desire, arousal, or overall sexual function versus placebo. “Worth discussing” is deliberately different from “proven to work.”
Oxytocin is an FDA-approved medicine used for specific obstetric purposes. The compounded preparation offered here is prescribed for a different purpose and is not the FDA-approved finished product. No compounded medication is FDA-approved, including this one. Compounded medicines are made to your individual prescription by a licensed pharmacy rather than manufactured and approved as a finished drug product.
Not in the conventional sense. Controlled studies have not consistently shown that administered oxytocin increases sexual desire, and some have found no meaningful improvement in desire or arousal versus placebo. If low desire is the primary concern, that distinction matters when your provider reviews the Assessment.
It is a catchy nickname for complicated biology. Oxytocin has established roles in reproduction and a large research record around social and emotional processing, but administering it does not reliably switch on love, bonding, attraction, or sexual function. The more interesting version of the story is also the more honest one: oxytocin is one signal inside systems that depend heavily on person, context, and outcome measured.
The molecule is only part of the decision. Here, a licensed provider looks at what has actually changed, whether oxytocin is a medically reasonable thing to explore, and what else in your health or treatment plan may matter. A licensed US pharmacy compounds the prescription if treatment is approved. The FDA has found products sold as research chemicals under false labels, some naming compounding pharmacies that do not exist, and warns they “can pose risks of serious harm” by bypassing the body’s defenses.F4 Testing has found wide variation in purity and in how much of the compound is actually in the vial. That difference is especially important with a product surrounded by as much mythology as oxytocin. AnthologyRX puts the biology back inside medicine.
A compounded bremelanotide injection that enters sexual response through central melanocortin signaling rather than genital blood flow.
A clinician-selected compounded rapid-dissolve tablet that brings two familiar timing profiles into one individualized prescription.
A compounded three-part prescription for cases where vascular response may not be the only layer worth evaluating.